Cargando…

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs

BACKGROUND: Monitoring hepatitis C virus (HCV) incidence is important for assessing intervention impact. Longitudinal studies of people who inject drugs (PWID), using repeated biological tests, are costly; alternatively, incidence can be estimated using biological markers of recent infection in cros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hope, Vivian D, Harris, Ross J, Vickerman, Peter, Platt, Lucy, Shute, Justin, Cullen, Katelyn J, Ijaz, Samreen, Mandal, Sema, Ncube, Fortune, Desai, Monica, Parry, John V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341939/ https://www.ncbi.nlm.nih.gov/pubmed/30482265 http://dx.doi.org/10.2807/1560-7917.ES.2018.23.47.1700635

Ejemplares similares

Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992–2013
por: Hope, Vivian D., et al.
Publicado: (2016)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018
por: Bardsley, Megan, et al.
Publicado: (2021)

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
por: Harris, R. J., et al.
Publicado: (2016)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England
por: Hope, Vivian, et al.
Publicado: (2008)

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
por: Stone, Jack, et al.
Publicado: (2020)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on
por: Croxford, Sara, et al.
Publicado: (2022)

HCV entry receptors as potential targets for siRNA-based inhibition of HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Modelling the impact and cost‐effectiveness of non‐governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine
por: Stone, Jack, et al.
Publicado: (2023)

Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships
por: Hahn, Judith A, et al.
Publicado: (2019)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016
por: Ireland, Georgina, et al.
Publicado: (2019)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
por: Campbell, Cecily A., et al.
Publicado: (2017)

Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania
por: Fraser, Hannah, et al.
Publicado: (2021)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

HCV Subtype Characterization among Injection Drug Users: Implication for a Crucial Role of Zhenjiang in HCV Transmission in China
por: Zhang, Chiyu, et al.
Publicado: (2011)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
por: Nguyen, Truong Tam, et al.
Publicado: (2018)

Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
por: Aponte-Meléndez, Yesenia, et al.
Publicado: (2023)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts
por: Stopka, Thomas J., et al.
Publicado: (2022)

The signal-to-cutoff ratios to predict HCV infection among people who inject drugs
por: Chen, Bing, et al.
Publicado: (2022)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
por: Tien Ng, Kim, et al.
Publicado: (2015)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact
por: Martin, N K, et al.
Publicado: (2015)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p9pl35pvv766g7dslv0sepnpv7